Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
Farsalinos, K.; Eliopoulos, E.; Leonidas, D.D.; Papadopoulos, G.E.; Tzartos, S.; Poulas, K. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications. Int. J. Mol. Sci. 2020, 21, 5807. https://doi.org/10.3390/ijms21165807
Farsalinos K, Eliopoulos E, Leonidas DD, Papadopoulos GE, Tzartos S, Poulas K. Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications. International Journal of Molecular Sciences. 2020; 21(16):5807. https://doi.org/10.3390/ijms21165807
Chicago/Turabian StyleFarsalinos, Konstantinos; Eliopoulos, Elias; Leonidas, Demetres D.; Papadopoulos, Georgios E.; Tzartos, Socrates; Poulas, Konstantinos. 2020. "Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications" Int. J. Mol. Sci. 21, no. 16: 5807. https://doi.org/10.3390/ijms21165807